TransMedics Group Reports Impressive Financial Growth in Q1 2025 TransMedics Group, Inc. showcases a remarkable 48% revenue increase in Q1 2025, accompanied by a net income growth, highlighting its commitment to organ transplant innovation.

TransMedics Group Reports Impressive Financial Growth in Q1 2025 #United_States #TransMedics #Nasdaq_TMDX #Andover #OCS

TransMedics Group to Host a Key Investor & Analyst Day in December 2024 TransMedics Group, a leader in organ transplant technology, will host an Investor & Analyst Day in New York City on December 10, 2024, detailing its growth strategy.

TransMedics Group to Host a Key Investor & Analyst Day in December 2024 #United_States #New_York #TransMedics #Nasdaq_TMDX #investor_events